Topics
High-grade gliomas | Treatment | Targeted therapy | Ipilimumab
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Ipilimumab
Duerinck J, Lescrauwaet L, Dirven I, Del'haye J, Stevens L,
Geeraerts X, Vaeyens F, Geens W, Brock S, Vanbinst AM, Everaert H,
Caljon B, Bruneau M, Lebrun L, Salmon I, Kockx M, Tuyaerts S,
Neyns B.
Intracranial administration
of anti-PD-1
and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies
in patients
with recurrent high-grade glioma.
Neuro
Oncol. 2024 Oct 16:noae177. doi:
10.1093/neuonc/noae177. PMID:
39406392. Interventional study. ˍ